Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.
Previous Story
Hillary Clinton Sees a Dangerous Moment for Women’s Rights, and Democracy
Next Story
U.S. allies’ recognition of a Palestinian state puts them in opposition to the White House.
